27 - 29 May, 2026
Congress CenterBasel Switzerland Kevin Parker, Ph.DCEO at Cartography BiosciencesSpeaker
Profile
Kevin Parker is the CEO and co-founder of Cartography Biosciences. Cartography is advancing a pipeline of antibody therapeutics in oncology from its platform to identify cell-specific targets. Kevin received his PhD from Stanford University in Stem Cell Biology and Regenerative Medicine and his BA from Harvard College in Human Developmental Regenerative Biology. At Cartography, Kevin is motivated to advance therapeutics for patients; and outside of Cartography, Kevin is an avid rock climber.
Agenda Sessions
Identification of Optimal Antigen Targets and Target Pairs for T-cell Engagers Using Single-cell Genomics
, 14:35View Session